News
11-28-2007, 03:41 AM
GlaxoSmithKline PLC sent misleading letters to health professionalstouting its breast cancer drug Tykerb, U.S. health officials saidin a letter released on Monday.
More... (http://www.healthcentral.com/breast-cancer/news-196285-66.html)
More... (http://www.healthcentral.com/breast-cancer/news-196285-66.html)